|
BAT2L2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.823370E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.055710E-02 |
| Normal-vs-Stage2 |
1.66310000004888E-06 |
| Normal-vs-Stage3 |
8.200300E-03 |
| Normal-vs-Stage4 |
2.811400E-01 |
| Stage1-vs-Stage2 |
1.535970E-03 |
| Stage1-vs-Stage3 |
6.327600E-01 |
| Stage1-vs-Stage4 |
4.591200E-01 |
| Stage2-vs-Stage3 |
1.569660E-02 |
| Stage2-vs-Stage4 |
3.022300E-03 |
| Stage3-vs-Stage4 |
2.907800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.021840E-02 |
| Normal-vs-AfricanAmerican |
2.400000E-01 |
| Normal-vs-Asian |
2.051700E-02 |
| Caucasian-vs-AfricanAmerican |
7.175800E-01 |
| Caucasian-vs-Asian |
6.557400E-01 |
| AfricanAmerican-vs-Asian |
5.158600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.642000E-03 |
| Normal-vs-Female |
3.503200E-03 |
| Male-vs-Female |
6.931600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.893800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.164240E-03 |
| Normal-vs-Age(61-80Yrs) |
5.524900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.054000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.227000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.885000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.893000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.424000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.013400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.157200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.713810E-01 |
| Classical-VS-Follicular |
7.20289999978085E-07 |
| Classical-VS-Other |
1.495030E-01 |
| Classical-VS-Normal |
2.855400E-01 |
| Tall-VS-Follicular |
6.098700E-03 |
| Tall-VS-Other |
2.808200E-01 |
| Tall-VS-Normal |
5.183600E-02 |
| Follicular-VS-Other |
6.710400E-01 |
| Follicular-VS-Normal |
7.81290000029244E-07 |
| Other-VS-Normal |
3.640100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98829999999983E-05 |
| Normal-vs-N1 |
5.261800E-01 |
| N0-vs-N1 |
1.018330E-02 |
|
|
